<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03128580</url>
  </required_header>
  <id_info>
    <org_study_id>1703-VLC-021-EL</org_study_id>
    <nct_id>NCT03128580</nct_id>
  </id_info>
  <brief_title>Embryo Aneuploidies and Morphokinetics in Ovarian Stimulated and Non Stimulated IVF Cycles</brief_title>
  <acronym>AMOS</acronym>
  <official_title>Embryo Aneuploidies and Morphokinetics in Ovarian Stimulated and Non Stimulated Cycles. An Intrapatient Comparison Using Next Generation Sequencing in Biopsy of Blastocysts and Time Lapse Evaluation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Valenciano de Infertilidad, IVI VALENCIA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Valenciano de Infertilidad, IVI VALENCIA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the number of euploid embryos obtained per metaphase
      II oocyte in unstimulated (modified natural cycles) and stimulated IVF cycles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Effects of ovarian stimulation on human embryo quality is still a subject of study. When
      natural and stimulated cycles have been compared, no differences have been observed in terms
      of embryo cleavage capacity, oocyte and embryo aneuploidy rate or incidence of aneuploidy in
      aborted foetuses. When mild and conventional doses of gonadotropins have been compared, a
      higher proportion of good morphological quality embryos are observed in the former. On the
      contrary, we showed that ovarian stimulation does not increase significantly the embryo
      aneuploidy rate in IVF derived human embryos when unstimulated and stimulated cycles were
      compared in oocyte donors. In this study, we want to compare the embryo aneuploidy rate
      between unstimulated and stimulated cycles in infertile patients, subjected to both IVF
      cycles with blastocyst biopsy and NGS-PGS. A comparison of the morphokinetics will also be
      performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the number of euploid embryos from Metaphase II oocytes in different cohorts of embryos.</measure>
    <time_frame>30 days</time_frame>
    <description>Number of metaphase II oocyte per euploid embryo in unstimulated and stimulated cycles.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of embryo aneuploidies in two cohorts of embryos.</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of embryo aneuploidies between the unstimulated and stimulated cycle in the same patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphokinetic evaluation of embryos in two different cohorts of embryos.</measure>
    <time_frame>30 days</time_frame>
    <description>Morphokinetic evaluation of the embryos obtained in an unstimulated and stimulated cycle</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Euploid Embryos</condition>
  <arm_group>
    <arm_group_label>Natural Cycle</arm_group_label>
    <description>The patient will not undergo hyperstimulation rather a natural cycle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stimulated Cycle</arm_group_label>
    <description>The 80 patients will undergo hyperstimulation cycle as per the clinical practice planned for the patient.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing In Vitro Fertilization treatment
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women

          -  30-38 years old (inclusive)

          -  with regular menstrual cycles (25-35 days)

          -  AntiMÃ¼lleriana Hormone &gt;5 pmol/L.

          -  Undergoing IVF treatment

        Exclusion Criteria:

          -  BMI &gt;30 kg/m2

          -  repeated miscarriages

          -  implantation failure

          -  uterine or adnexal pathology

          -  Unable to be treated with gonadotrophins for the ovarian hyperstimulation

          -  history of low response to ovarian hyperstimulation

          -  participation in another study with PGS for monogenic pathology

          -  Cryptozoospermia in male partner
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women undergoing fertility treatment</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Elena Labarta, MDPhD</last_name>
    <phone>+34963050900</phone>
    <email>elena.labarta@ivi.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leslie Atkinson, MA</last_name>
    <phone>+34963050925</phone>
    <email>leslie.atkinson@ivi.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ernesto Bosch, MDPhD</last_name>
      <phone>963050900</phone>
      <email>ernesto.bosch@ivi.es</email>
    </contact>
    <contact_backup>
      <last_name>Leslie Atkinson, MA</last_name>
      <phone>963050925</phone>
      <email>leslie.atkinson@ivi.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Instituto Valenciano de Infertilidad Spain</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ELENA LABARTA, MD</last_name>
      <phone>34 96 3050900</phone>
      <email>elabarta@ivi.es</email>
    </contact>
    <investigator>
      <last_name>Jose Bellver, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Labarta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Labarta, MD PhD</last_name>
      <phone>+34963050900</phone>
      <email>Elena.labarta@ivi.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <last_update_submitted>December 14, 2017</last_update_submitted>
  <last_update_submitted_qc>December 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneuploidy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

